Top

Published in:

Open Access 01-12-2020 | Contraception | Review Article

Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy

Authors: Yasser El Miedany, Deborah Palmer

Published in: Clinical Rheumatology | Issue 12/2020

Abstract

The autoimmune rheumatic diseases have a clear predilection for women. Consequently, issues regarding family planning and pregnancy are a vital component of the management of these patients. Not only does pregnancy by itself causes physiologic/immunologic changes that impact disease activity but also women living with inflammatory arthritic conditions face the additional challenges of reduced fecundity and worsened pregnancy outcomes. Many women struggle to find adequate information to guide them on pregnancy planning, lactation and early parenting in relation to their chronic condition. This article discusses the gaps in the care provided to women living with inflammatory arthritis in standard practice and how a rheumatology nurse-led pregnancy clinic would fill such gap, consequently enhance the care provided and ensure appropriate education is provided to these individuals who represent the majority of the patients attending the rheumatology outpatient clinics. Such specialist care is expected to cover the whole journey as it is expected to provide high-quality care before, during and after pregnancy.

Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF (2014) Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry. Acta Obstet Gynecol Scand 93(3):302–307PubMed

Cauldwell M, Nelson-Piercy C (2012) Maternal and fetal complications of systemic lupus erythematosus. Obstet Gynaecol 14:167–174

Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR (2002) Psoriasis and pregnancy. J Cutan Med Surg 6:561–570PubMed

Kurizky PS, Ferreira Cde C, Nogueira LS, Mota LM (2015) Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. An Bras Dermatol 90(3):367–375PubMed

Al-Emadi S, Abutiban F, El Zorkany B, Ziade N, Al-Herz A, Al-Maini M (2016) Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East. Clin Rheumatol 35:25–31PubMed

El Miedany Y (2013) PROMs in inflammatory arthritis: moving from static to dynamic. Clin Rheumatol 32:735–742PubMed

Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C (2014) Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open 4:e004081PubMed

Toomey D, Waldron B (2013) Family planning and inflammatory bowel disease: the patient and the practitioner. Fam Pract 30:64–68PubMed

Akers AY, Gold MA, Borrero S, Santucci A, Schwarz EB (2010) Providers’ perspectives on challenges to contraceptive coun-seling in primary care settings. J Women's Health 19:1163–1170

10.

Vancsa A, Ponyi A, Constantin T, Zeher M, Danko K (2007) Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int 27:435–439PubMed

11.

Ostensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME (2015) State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 14:376–386PubMed

12.

El Miedany Y, Palmer D (2008) Can standard rheumatology clinical practice be patient-based? Br J Nurs 17(10):673–675PubMed

13.

Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD (2015) Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med 163:153–163PubMed

14.

Ngian GS, Briggs AM, Ackerman IN, Van Doornum S (2016) Management of pregnancy in women with rheumatoid arthritis. Med J Aust 204:62–63PubMed

15.

Huong LD, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefebvre G, Bletry O (1997) Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62pregnancies. Br J Rheumatol 36:772–777PubMed

16.

Soh MC, Nelson-Piercy C (2015) High-risk pregnancy and the rheumatologist. Rheumatology (Oxford) 54:572–587

17.

Briggs AM, Jordan JE, Ackerman IN, Van Doornum S (2016) Establishing cross-discipline consensus on contraception, pregnancy and breast feeding-related educational messages and clinical practices to support women with rheumatoid arthritis: an Australian Delphi study. BMJ Open 6:e012139PubMed

18.

Talabi M, Clowse M, Schwarz E, Callegar L, Morel L, Borrero OS (2018) Family planning counselling for women with rheumatic diseases. Arthritis Care Res 70(2):169–174

19.

Curtis KM, Peipert JF (2017) Long-acting reversible contraception. N Engl J Med 376:461–468PubMed

20.

Lanza LL, McQuay LJ, Rothman KJ, Bone HG, Kaunitz AM, Harel Z (2013) Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture. Obstet Gynecol 121:593–600PubMed

21.

Curtis KT, Tepper NK, Zapata L, Horton L, Jamieson DJ, Whiteman MK (2016) Medical eligibility criteria for contraceptive use. MMWR Recomm Rep 65:1–103.23PubMed

22.

Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K (2012) Effects of infertility, pregnancy loss and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 64:668–674

23.

Heit JA, Kobbervig CE, James AH, Petterson TM, BaileyKR MLJ III (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143:697–706PubMed

24.

Bermas B, Sammaritano L (2015) Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Fertil Res Pract 1:13–18PubMed

25.

Jawaheer D, Zhu JL, Nohr EA, Olsen J (2011) Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 63(6):1517–1521PubMed

26.

Brouwer J, Hazes JM, Laven JS, Dolhain RJ (2015) Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 74(10):1836–1841PubMed

27.

Pasoto SG, Mendonca BB, Bonfa E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical hormonal and therapeutic associations. Lupus 11:175–180PubMed

28.

Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD (2000) Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 43:550–556PubMed

29.

Huong DL, Wechsler B, Vauthier-Brouzes D, Duhat P, Costedoat N, Lefebre G (2002) Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Sem Arthritis Rheum 32(3):174–188

30.

de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM (2008) Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 59(9):1241–1248PubMed

31.

Barrett JH, Brennan P, Fiddler M, Silman AJ (1999) Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 42(6):1219–1227PubMed

32.

de Man YA, Hazes JM, van de Geijn FE, Krommenhoek C, Dolhain RJ (2007) Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum 57(5):716–722PubMed

33.

Carvalheiras G, Vita P, Marta S, Trovao R, Farinha F, Braga J, Rocha G, Almeida I, Marinho A, Mendonca T (2010) Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol 38(2–3):302–306PubMed

34.

Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, Buchanan NM (1996) Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35(2):133–138PubMed

35.

Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52(2):514–521

36.

Nørgaard M, Larsson H, Pedersen L (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268(4):329–337

37.

Wallenius M, Skomsvoll JF, Irgens LM (2011) Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 63(6):1534–1542

38.

de Man YA, Hazes JM, van der Heide H et al (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 60(11):3196–3206PubMed

39.

Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 41(6):643–650

40.

Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 32(9):1709–1712PubMed

41.

Gladman DD, Tandon A, Ibanez D, Urowitz MB (2010) The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 37(4):754–758PubMed

42.

Clowse ME, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54(11):3640–3647PubMed

43.

Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J et al (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178(6):701–711PubMed

44.

Huong LTD, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR, Lefebvre G, Piette JC (2006) The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45(3):332–338

45.

Lateef A, Petri M (2013) Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 27(3):435–447PubMed

46.

Reed SD, Vollan TA, Svec MA (2006) Pregnancy outcomes in women with rheumatoid arthritis in Washington state. Matern Child Health J 10(4):361–366PubMed

47.

Rom AL, Wu CS, Olsen J (2014) Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol 66(12):3265–3273PubMed

48.

Krause M, Makol A (2016) Management of rheumatoid arthritis during pregnancy: challenges and solutions. Rheumatol Res Rev 8:23–36

49.

Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M (2016) BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology 55:16931697

50.

Barrett JH, Brennan P, Fiddler M, Silman A (2000) Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 43(5):1010PubMed

51.

Ost L, Wettrell G, Björkhem I, Rane A (1985) Prednisolone excretion in human milk. J Pediatr 106(6):1008–1011PubMed

52.

American Academy of Pediatrics Committee on Drugs (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108(3):776–789

53.

Ling J, Koren G (2016) Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy. Expert Rev Vaccines 15:239–256PubMed

54.

Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, Bibby BM, Uldbjerg N, Connell WR, Rosella O, Grosen A, Brown SJ, Kjeldsen J, Wildt S, Svenningsen L, Sparrow MP, Walsh A, Connor SJ, Radford-Smith G, Lawrance IC, Andrews JM, Ellard K, Bell SJ (2016) Concentrations of Adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology 151:110–119PubMed

55.

Mahadevan U, Wolf DC, Dubinsky M (2013) Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11:286–292PubMed

56.

Zelinkova Z, de Haar C, de Ridder L (2011) High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther 33:1053–1058PubMed

57.

Murashima A, Watanabe N, Ozawa N (2009) Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant’s serum. Ann Rheum Dis 68:1793–1794PubMed

58.

Berthelsen BG, Fjeldsøe-Nielsen H, Nielsen CT (2010) Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding. Rheumatology 49:2225–2227PubMed

59.

Friedrichs B, Tiemann M, Salwender H (2006) The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91:1426–1427PubMed

60.

Mahadevan U, Cucchiara S, Hyams JS (2011) The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European Crohn’s and colitis organisation: pregnancy and pediatrics. Am J Gastroenterol 106:214–223PubMed

61.

Mariette X, Förger F, Abraham B (2018) Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis 77:228–233PubMed

62.

Förger F, Zbinden A, Villiger PM (2016) Certolizumab treatment during late pregnancy in patients with rheumatic diseases: low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients. Joint Bone Spine 83:341–343PubMed

63.

Cheent K, Nolan J, Shariq S et al (2010) Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s disease. J Crohns Colitis 4:603–605PubMed

64.

Gisbert JP, Chaparro M (2013) Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol 108:1426–1438PubMed

65.

Götestam Skorpen C, Hoeltzenbein M, Tincani A (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795–810PubMed

Title: Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy
Authors: Yasser El Miedany
Deborah Palmer
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: Contraception
Systemic Lupus Erythematosus
Care
Rheumatoid Arthritis
Published in: Clinical Rheumatology / Issue 12/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05173-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients

Correction to: In shoulder adhesive capsulitis, ultrasound-guided anterior hydrodilatation in rotator interval is more effective than posterior approach: a randomized controlled study

Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases

Performance of the 2017 EUSTAR activity index in an scleroderma cohort

Interleukin-29 regulates T follicular helper cells by repressing BCL6 in rheumatoid arthritis patients

Moyamoya syndrome related to systemic lupus erythematosus developing during pregnancy: a case-based review

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials